People News: Roche NimbleGen and ISI

Share this article:
Roche NimbleGen named Frank Pitzer CEO. Dr. Pitzer was previously head of divisional quality and regulatory affairs at Roche Diagnostics, reporting directly to the CEO, and was also a member of the Diagnostics executive committee.

ISI, a life sciences software company, named Lisa Jenkins, PhD director of regulatory strategy, responsible for advising clients on clinical development and global strategic regulatory affairs. Jenkins was previously associate director/regulatory group leader at Kendle International, and before that she was the principal statistician and senior manager of regulatory affairs at Wyeth.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.